A model of tumor architecture and spatial interactions with tumor microenvironment in breast carcinoma

Breast carcinomas are cancers that arise from the epithelial cells of the breast, which are the cells that line the lobules and the lactiferous ducts. Breast carcinoma is the most common type of breast cancer and can be divided into different subtypes based on architectural features and growth patterns, recognized during a histopathological examination. Tumor microenvironment (TME) is the cellular environment in which tumor cells develop. Being composed of various cell types having different biological roles, TME is recognized as playing an important role in the progression of the disease. The architectural heterogeneity in breast carcinomas and the spatial interactions with TME are, to date, not well understood. Developing a spatial model of tumor architecture and spatial interactions with TME can advance our understanding of tumor heterogeneity. Furthermore, generating histological synthetic datasets can contribute to validating, and comparing analytical methods that are used in digital pathology. In this work, we propose a modeling method that applies to different breast carcinoma subtypes and TME spatial distributions based on mathematical morphology. The model is based on a few morphological parameters that give access to a large spectrum of breast tumor architectures and are able to differentiate in-situ ductal carcinomas (DCIS) and histological subtypes of invasive carcinomas such as ductal (IDC) and lobular carcinoma (ILC). In addition, a part of the parameters of the model controls the spatial distribution of TME relative to the tumor. The validation of the model has been performed by comparing morphological features between real and simulated images.

[1]  Paolo P. Provenzano,et al.  Collagen reorganization at the tumor-stromal interface facilitates local invasion , 2006, BMC medicine.

[2]  Pierre Gançarski,et al.  Combat or surveillance? Evaluation of the heterogeneous inflammatory breast cancer microenvironment , 2013, The Journal of pathology.

[3]  Yinyin Yuan,et al.  Modelling the spatial heterogeneity and molecular correlates of lymphocytic infiltration in triple-negative breast cancer , 2015, Journal of The Royal Society Interface.

[4]  Umed A. Ajani,et al.  The Changing Incidence of In situ and Invasive Ductal and Lobular Breast Carcinomas: United States, 1999-2004 , 2009, Cancer Epidemiology Biomarkers & Prevention.

[5]  Mike J. Irwin,et al.  Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer , 2016, Breast Cancer Research.

[6]  L. Coussens,et al.  The inflammatory tumor microenvironment and its impact on cancer development. , 2006, Contributions to microbiology.

[7]  Sidra Nawaz,et al.  Beyond immune density: critical role of spatial heterogeneity in estrogen receptor-negative breast cancer , 2015, Modern Pathology.

[8]  Susan Holmes,et al.  Quantitative, Architectural Analysis of Immune Cell Subsets in Tumor-Draining Lymph Nodes from Breast Cancer Patients and Healthy Lymph Nodes , 2010, PloS one.

[9]  D. Chen,et al.  Spatial organization of dendritic cells within tumor draining lymph nodes impacts clinical outcome in breast cancer patients , 2013, Journal of Translational Medicine.

[10]  Nasir M. Rajpoot,et al.  A model of the spatial microenvironment of the colonic crypt , 2015, 2015 IEEE 12th International Symposium on Biomedical Imaging (ISBI).

[11]  Paolo P. Provenzano,et al.  Aligned Collagen Is a Prognostic Signature for Survival in Human Breast Carcinoma Address Reprint Requests to See Related Commentary on Page 966 , 2022 .

[12]  V. Band,et al.  Histological, molecular and functional subtypes of breast cancers , 2010, Cancer biology & therapy.

[13]  Nasir M. Rajpoot,et al.  A model of the spatial tumour heterogeneity in colorectal adenocarcinoma tissue , 2016, BMC Bioinformatics.